Our Outlook for the Health-Care Sector
Political and regulatory changes could sway biotech and drug stocks.
Compared with other industries, health care is more vulnerable to external forces including political and regulatory actions. We have recently seen a few potential changes on the horizon that could blow a cool wind over pharmaceutical, biotech, and medical device companies.
Debbie Wang has a position in the following securities mentioned above: NVS, PFE, VTRS. Find out about Morningstar’s editorial policies.